Hepatitis B immunoglobulin (Tonrol Biopharmaceutical)

乙型肝炎人免疫球蛋白（同路生物）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameHepatitis B immunoglobulin (Tonrol Biopharmaceutical)
Drug Alias Name冻干静注乙型肝炎人免疫球蛋白（pH4）（同路生物）
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2002/12/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonrol Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTonrol Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A